Analysts Set Expectations for Transcat Q1 Earnings

Transcat, Inc. (NASDAQ:TRNS) – Northland Securities issued their Q1 2027 earnings per share estimates for Transcat in a report released on Thursday, May 28th. Northland Securities analyst T. Jackson forecasts that the scientific and technical instruments company will post earnings of $0.41 per share for the quarter. The consensus estimate for Transcat’s current full-year earnings is $1.71 per share. Northland Securities also issued estimates for Transcat’s Q2 2027 earnings at $0.45 EPS, Q3 2027 earnings at $0.38 EPS and FY2029 earnings at $3.18 EPS.

Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, May 26th. The scientific and technical instruments company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.05. The business had revenue of $89.33 million during the quarter, compared to analyst estimates of $89.79 million. Transcat had a return on equity of 5.84% and a net margin of 1.62%.

A number of other research analysts have also commented on TRNS. Weiss Ratings upgraded Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Transcat has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.

Transcat Stock Performance

Shares of NASDAQ TRNS opened at $84.52 on Monday. The business has a fifty day simple moving average of $76.20 and a 200 day simple moving average of $68.46. The company has a current ratio of 2.33, a quick ratio of 1.99 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $789.42 million, a price-to-earnings ratio of 145.73 and a beta of 0.71. Transcat has a one year low of $50.23 and a one year high of $91.45.

Institutional Trading of Transcat

Large investors have recently bought and sold shares of the stock. Lazard Asset Management LLC bought a new stake in Transcat in the second quarter valued at $54,000. Tower Research Capital LLC TRC grew its position in Transcat by 245.5% in the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock valued at $97,000 after acquiring an additional 798 shares during the period. PNC Financial Services Group Inc. grew its position in Transcat by 42.7% in the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock valued at $112,000 after acquiring an additional 458 shares during the period. Jones Financial Companies Lllp grew its position in Transcat by 79.2% in the third quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock valued at $120,000 after acquiring an additional 722 shares during the period. Finally, AlphaQuest LLC grew its stake in Transcat by 12,915.4% during the third quarter. AlphaQuest LLC now owns 1,692 shares of the scientific and technical instruments company’s stock worth $124,000 after buying an additional 1,679 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.